Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Julphar
Federal Trade Commission
Cipla
Daiichi Sankyo
Cerilliant
US Department of Justice
Covington
Colorcon

Generated: August 22, 2017

DrugPatentWatch Database Preview

EMETE-CON Drug Profile

« Back to Dashboard

Which patents cover Emete-con, and when can generic versions of Emete-con launch?

Emete-con is a drug marketed by Roerig and Pfizer and is included in two NDAs.

The generic ingredient in EMETE-CON is benzquinamide hydrochloride. Additional details are available on the benzquinamide hydrochloride profile page.

Summary for Tradename: EMETE-CON

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list11
Clinical Trials: see list44
Patent Applications: see list13
Drug Prices:see details
DailyMed Link:EMETE-CON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roerig
EMETE-CON
benzquinamide hydrochloride
SUPPOSITORY;RECTAL016818-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
EMETE-CON
benzquinamide hydrochloride
INJECTABLE;INJECTION016820-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Deloitte
Boehringer Ingelheim
Express Scripts
Novartis
Cantor Fitzgerald
Argus Health
UBS
Cipla
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot